LYTIR

Company · HCAT

Health Catalyst, Inc

Name as listed on its exchange; filed with the SEC as Health Catalyst, Inc.

Nasdaq's symbol directory lists HCAT on Nasdaq as “Health Catalyst, Inc - Common stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($105K); 1 planned-sale notice; 4 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Kohl Simeon, Chief Executive Officer bought on 1 day latest Sep 14, 2026 bought $105K
Every trade (1)
  1. BUYKohl Simeon, Chief Executive Officer bought Sep 14, 2026 59,000 shares filing $105K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Benjamin Albert filed Sep 10, 2026 Officer 35,244 shares planned sale date 09/10/2026 filing $59K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Palogic Value Management, LP filed Sep 8, 2026 Schedule 13D/A may seek influence 5,374,949 shares filing 7.1%
  2. Stoney Lonesome HF LP filed Aug 14, 2026 Schedule 13G/A passive filing 9.6%
  3. Impax Asset Management Group plc filed Jul 21, 2026 Schedule 13G passive 4,000,000 shares filing 5.4%
  4. Palogic Value Management, L.P. filed Jun 22, 2026 Schedule 13D may seek influence 4,918,866 shares filing 6.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Departure or appointment of directors or officers; Regulation FD disclosure filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.